UA114101C2 - Трансдермальна терапевтична система для введення фентанілу або його аналога - Google Patents

Трансдермальна терапевтична система для введення фентанілу або його аналога

Info

Publication number
UA114101C2
UA114101C2 UAA201407194A UAA201407194A UA114101C2 UA 114101 C2 UA114101 C2 UA 114101C2 UA A201407194 A UAA201407194 A UA A201407194A UA A201407194 A UAA201407194 A UA A201407194A UA 114101 C2 UA114101 C2 UA 114101C2
Authority
UA
Ukraine
Prior art keywords
analog
therapeutic system
transdermal therapeutic
fentanil
introducing
Prior art date
Application number
UAA201407194A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of UA114101C2 publication Critical patent/UA114101C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B37/00—Methods or apparatus for laminating, e.g. by curing or by ultrasonic bonding
    • B32B37/14—Methods or apparatus for laminating, e.g. by curing or by ultrasonic bonding characterised by the properties of the layers
    • B32B37/26—Methods or apparatus for laminating, e.g. by curing or by ultrasonic bonding characterised by the properties of the layers with at least one layer which influences the bonding during the lamination process, e.g. release layers or pressure equalising layers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B38/00—Ancillary operations in connection with laminating processes
    • B32B38/0004—Cutting, tearing or severing, e.g. bursting; Cutter details
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B37/00—Methods or apparatus for laminating, e.g. by curing or by ultrasonic bonding
    • B32B37/14—Methods or apparatus for laminating, e.g. by curing or by ultrasonic bonding characterised by the properties of the layers
    • B32B37/26—Methods or apparatus for laminating, e.g. by curing or by ultrasonic bonding characterised by the properties of the layers with at least one layer which influences the bonding during the lamination process, e.g. release layers or pressure equalising layers
    • B32B2037/268—Release layers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2323/00—Polyalkenes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2556/00—Patches, e.g. medical patches, repair patches
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T156/00—Adhesive bonding and miscellaneous chemical manufacture
    • Y10T156/10—Methods of surface bonding and/or assembly therefor
    • Y10T156/1052—Methods of surface bonding and/or assembly therefor with cutting, punching, tearing or severing

Abstract

У винаході пропонується трансдермальна терапевтична система для введення фентанілу або його аналога через шкіру, яка має матричний шар, що сам клеїться, який містить суміш двох поліізобутиленів з певним модулем зберігання.
UAA201407194A 2011-11-30 2012-11-22 Трансдермальна терапевтична система для введення фентанілу або його аналога UA114101C2 (xx)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11191254.9A EP2599478A1 (de) 2011-11-30 2011-11-30 Transdermales therapeutisches System zur Verabreichung von Fentanyl oder einem Analogstoff davon
PCT/EP2012/073314 WO2013079386A1 (de) 2011-11-30 2012-11-22 Transdermales therapeutisches system zur verabreichung von fentanyl oder einem analogstoff davon

Publications (1)

Publication Number Publication Date
UA114101C2 true UA114101C2 (xx) 2017-04-25

Family

ID=47226157

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201407194A UA114101C2 (xx) 2011-11-30 2012-11-22 Трансдермальна терапевтична система для введення фентанілу або його аналога

Country Status (11)

Country Link
US (1) US20140330223A1 (uk)
EP (2) EP2599478A1 (uk)
JP (1) JP2015502940A (uk)
KR (1) KR101968366B1 (uk)
AR (1) AR089040A1 (uk)
CA (1) CA2850906C (uk)
EA (1) EA032150B1 (uk)
MX (1) MX2014005437A (uk)
UA (1) UA114101C2 (uk)
WO (1) WO2013079386A1 (uk)
ZA (1) ZA201403497B (uk)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102014000200A1 (de) * 2014-01-03 2015-07-09 Michael Horstmann Transdermales Therapeutisches System
EP3233081B1 (en) * 2014-12-19 2021-09-22 Kindeva Drug Delivery L.P. Transdermal drug delivery device including fentanyl
KR102290262B1 (ko) 2017-03-24 2021-08-13 이 잉크 캘리포니아 엘엘씨 활성 분자들을 전달하기 위한 마이크로셀 시스템들
KR102366628B1 (ko) 2017-03-24 2022-02-22 이 잉크 캘리포니아 엘엘씨 활성제들의 투여 속도를 조절하기 위해 하전 또는 자성 입자들을 포함하는 마이크로셀 전달 시스템
JP6972334B2 (ja) 2017-11-14 2021-11-24 イー インク カリフォルニア， エルエルシー 多孔性伝導電極層を含む電気泳動活性分子送達システム
WO2021108210A1 (en) 2019-11-27 2021-06-03 E Ink California, Llc Benefit agent delivery system comprising microcells having an electrically eroding sealing layer
WO2022093541A1 (en) 2020-10-29 2022-05-05 E Ink California, Llc Microcell systems for delivering benefit agents
JP2023545106A (ja) 2020-10-29 2023-10-26 イー インク カリフォルニア， エルエルシー 親水性活性分子を送達するためのマイクロセルシステム

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588580B2 (en) * 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
AU601528B2 (en) 1986-12-22 1990-09-13 Ortho-Mcneil Pharmaceutical, Inc. Resilient transdermal drug-delivery device and compositions and devices employing fatty acid esters/ethers of alkanediols and percutaneous absorption enhancers
DE19701949A1 (de) * 1997-01-13 1998-07-16 Jenapharm Gmbh Transdermales therapeutisches System
US5948433A (en) 1997-08-21 1999-09-07 Bertek, Inc. Transdermal patch
DE19830898A1 (de) 1998-07-10 2000-01-13 Hexal Ag Vorrichtung zur Verbesserung der Entnahmefähigkeit von in Beuteln verpackten, haftklebend ausgerüsteten, flächigen Substratabschnitten
JP3943724B2 (ja) 1998-07-31 2007-07-11 東光薬品工業株式会社 フェンタニル含有経皮投与マトリックス型貼付剤
MXPA03008349A (es) * 2001-03-16 2004-10-15 Johnson & Johnson Parche transdermico para administrar fentanilo.
JP4199485B2 (ja) * 2002-06-07 2008-12-17 久光製薬株式会社 貼付剤
JP4758101B2 (ja) 2002-09-13 2011-08-24 久光製薬株式会社 貼付剤
TWI296531B (en) 2002-10-18 2008-05-11 Hisamitsu Pharmaceutical Co Transdermal adhesive preparations for topical administration of fentanyl
KR100563194B1 (ko) * 2003-11-14 2006-03-21 (주) 에프디엘 펜타닐을 유효성분으로 함유하는 경피투여제제
JP4745747B2 (ja) 2004-08-12 2011-08-10 日東電工株式会社 フェンタニル含有貼付製剤
SI1814531T1 (sl) * 2004-10-21 2010-10-29 Durect Corp Transdermalni dostavni sistem
US8252319B2 (en) * 2004-10-21 2012-08-28 Durect Corporation Transdermal delivery system for sufentanil
JP4786196B2 (ja) * 2005-02-24 2011-10-05 ライオン株式会社 ゲル組成物及びその製造方法
BRPI0713104A2 (pt) * 2006-06-09 2012-10-16 Dainippon Sumitomo Pharma Co preparação de fita.
US8647664B2 (en) * 2006-07-14 2014-02-11 Hisamitsu Pharmaceutical Co., Inc. Adhesive preparation
EP2111857A1 (de) 2008-04-25 2009-10-28 Acino AG Transdermales therapeutisches System zur Verabreichung von Fentanyl oder einem Analogstoff hiervon
IN2012DN00845A (uk) 2009-07-21 2015-06-26 Mylan Inc
EP2295046B1 (de) * 2009-09-14 2012-12-19 Acino AG Transdermales therapeutisches System zur Verabreichung von Fentanyl oder einem Analogstoff davon

Also Published As

Publication number Publication date
WO2013079386A1 (de) 2013-06-06
JP2015502940A (ja) 2015-01-29
AR089040A1 (es) 2014-07-23
EP2785334A1 (de) 2014-10-08
CA2850906C (en) 2022-05-10
KR101968366B1 (ko) 2019-04-11
ZA201403497B (en) 2015-12-23
EA201400628A1 (ru) 2014-09-30
EA032150B1 (ru) 2019-04-30
KR20140098765A (ko) 2014-08-08
EP2599478A1 (de) 2013-06-05
CA2850906A1 (en) 2013-06-06
MX2014005437A (es) 2014-09-01
US20140330223A1 (en) 2014-11-06

Similar Documents

Publication Publication Date Title
UA114101C2 (xx) Трансдермальна терапевтична система для введення фентанілу або його аналога
CR20140321A (es) Sistema de administracion transdermica que contiene buprenofina
CY1121843T1 (el) Σκευασματα ετανερσεπτης σταθεροποιημενα με ιοντα μαγνησιου
CR20150647A (es) Sistema de liberación transdérmica
DOP2015000241A (es) Compuestos de biaril-amida como inhibidores de cinasa
CU20130094A7 (es) Moduladores de la vía del complemento
CL2015003185A1 (es) Aparato para la electroobtención o electrorefinación
CL2012001714A1 (es) Compuestos derivados de pirrol[3.4-b]piridin-5-ona, inhibidores de pi3k; composicion farmaceutica que los comprende; y uso para el tratamiento de enfermedades tales como alzheimer, epilepsia, esclerosis multiple, parkinson, entre otras.
CR20140161A (es) Benzilindazoles sustituidos para uso como inhibidores de la quinasa bub1 en el tratamiento de enfermedades hiperproliferativas
MX345344B (es) Sistema terapéutico transdérmico para la administración de una sustancia activa.
SV2011004061A (es) Aril-piridinas como inhibidores de sintasa de aldosterona
WO2012124966A3 (ko) 펜타닐 경피 패치제
CR20140508A (es) Moduladores de la ruta del complemento y usos de los mismos
CL2012003681A1 (es) Compuestos derivados de piperidina; composicion farmaceutica; y su uso como inhibidores de acetil-coa carboxilasa para el tratamiento de trastornos metabolicos, tales como obesidad y diabetes.
MY163809A (en) Transdermal drug delivery system containing donepezil
CL2014002978A1 (es) Combinaciones farmacéuticas que contienen un inhibidor de 11-beta-hidroxiesteroide dehidrogenasa para el tratamiento de trastornos metabólicos
BR112013012117A8 (pt) Sistema de distribuição de fármaco iontoforético coempacotado de utilização única coempacotado autocontido, usos de fármaco e de composto de triptano
CL2013000310A1 (es) Compuestos derivados de tetrahidrofuranilo disustituidos y sus sales, como antagonistas del receptor b1 de bradiquinina; medicamento que contiene a dichos compuestos; su procedimiento de preparacion, util para el tratamiento agudo o profilactico de dolores agudos, osteoartritis, asma, alergias, entre otras enfermedades.
CO6920289A2 (es) Composición farmacéutica oftalmológica tópica que contiene regorafenib.
BR112014017834A8 (pt) Sistema de distribuição de fármacos
MX361697B (es) Formulación transdérmica que contienen inhibidores de ciclooxigenasas (cox).
BR112014012945A2 (pt) sistemas, dispositivos e métodos para acionar um modulador interferométrico analógico
EA201790855A1 (ru) Трансдермальная терапевтическая система с высокой адгезивной способностью
EA201490390A1 (ru) Вспомогательное средство для накладывания
CL2014001643A1 (es) Compuestos derivados de quinolina, como inhibidores de la enzima pde10a; composicion farmaceutica que los comprende; y su uso para el tratamiento de un trastorno psiquiatrico o neurodegenerativo.